• About Us
    • Corporate Overview
    • Executive Leadership
      • Management team
      • Scientific Advisory Board
      • Board of Directors
      • Clinical Advisory Board
  • Our Science
    • Pipeline
      • Overview
      • AG-73305
      • AG-80308
      • AG-86893
    • Disease
      • Overview
      • DME
      • nAMD
      • Other Diseases
      • Pterygium
      • Dry Eye
    • Clinical Trial
  • Investor Relations
    • Investors
    • Press Release & Publications
    • Allgenesis In The News
  • Contact Us

Press Release & Publications

  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • News
  • All
  • 2015
  • 2018
  • 2019
  • 2020
  • 2021
  • 2022
  • 2023
  • All
  • admin
  • allgenesis
  • sky
2020-06-22

Allgenesis Receives Notice of Grant for AG-86893 in Korea and Japan for the Treatment of Pterygium

June 22nd, 2020 Allgenesis Biotherapeuti […]
Do you like it?
Read more
2020-06-08

Allgenesis Receives Notices of Grant of European, Japanese and Taiwan Patent for AG-73305, a Fusion Protein of VEGF Trap and Disintegrin

June 8th, 2020 Allgenesis Biotherapeutic […]
Do you like it?
Read more
2020-05-22

Allgenesis Signs Deal to In-License a Clinical Stage Drug Candidate for Dry Eye Disease

Taipei, Taiwan/ May 22nd, 2020 Allgenesi […]
Do you like it?
Read more
2020-02-20

Dr. Sunil Patel Joins Allgenesis’ Scientific Advisory Board

Taipei, Taiwan/ February 20th, 2020 Allg […]
Do you like it?
Read more
2020-02-05

Allgenesis Receives Notice of Grant of Japanese Patent for anti-VEGF/Disintegrin Fusion Protein

Taipei, Taiwan/ February 4th, 2020 Allge […]
Do you like it?
Read more
2020-01-21

Allgenesis: Final Database Lock Reaffirms Excellent Safety, Tolerability, and Signs of Efficacy from POC Phase 2a Study of AG-86893 in Patients with Pterygium

Taipei, Taiwan/ January 21st, 2020 Allge […]
Do you like it?
Read more

9F.-3, No.760, Sec. 4, Bade Rd.,
Songshan Dist., Taipei City 105,
Taiwan (R.O.C.)

Tel: +886-2-8787-1232
Fax: +886-2-8787-1239
Mail: info@allgenesis.com
Copyright © 2019 Allgenesis Biotherapeutics Inc. All rights reserved.